In-house roundup: AT&T chief sets sights on world IP alliance; Denmark 'perfect solution' for second medical use; top tips on in-house teams

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

In-house roundup: AT&T chief sets sights on world IP alliance; Denmark 'perfect solution' for second medical use; top tips on in-house teams

Drugs

Managing IP ties together the latest news and analysis from patent-focused businesses



Drugs

AT&T chief sets sights on new US and world IP alliance

Scott Frank, CEO and president of AT&T Intellectual Property, says he wants to improve IP practices for the good of society by helping launch new organisations modelled on the Georgia Intellectual Property Alliance. Read more... 

Denmark the ‘perfect solution’ to tackle second medical use infringement

Pharma innovators cite the Netherlands, Denmark, Norway and possibly the UPC as avenues to solve challenges around second medical use infringement. Read more... 

IBM, Ceres and Mereo give tips on building strong IP department

Panellists at the MIP European Patent Forum in Paris shared insights on how to build a strong IP department for businesses of any size. Read more... 





more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Palińska is the business & IP law lead at CD Projekt Red in Poland
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article